Justia U.S. Federal Circuit Court of Appeals Opinion Summaries
Articles Posted in U.S. Federal Circuit Court of Appeals
Brilliant Instruments, Inc. v. GuideTech, LLC
The patents generally relate to circuits that measure the timing errors of digital signals in high-speed microprocessors. These circuits, which are referred to as time interval analyzers, detect timing errors by analyzing a digital circuit’s clock signal and output signals. The inventor left GuideTech to found Brilliant. Brilliant obtained a judgment that its product did not infringe GuideTech’s patents. The Federal Circuit reversed and remanded. Detailed application of the function-way-result test to the claim element and the allegedly equivalent feature of the accused product were sufficient to create a genuine issue of material fact for the jury to resolve. The main difference between the accused circuit and the claimed circuit is that the capacitor in the accused circuit aids in delivering power and is thus part of the first current circuit. There is no evidence suggesting that this added advantage of the accused design alters the function-way-result analysis. View "Brilliant Instruments, Inc. v. GuideTech, LLC" on Justia Law
Posted in:
Patents, U.S. Federal Circuit Court of Appeals
McGuire v. United States
McGuire leased farmland in Arizona from the Colorado River Indian Tribes with approval of the Bureau of Indian Affairs. After the BIA removed a bridge that he used to access portions of the leased property, McGuire filed a Fifth Amendment claim. McGuire does not claim that removal of the bridge was itself a taking, but rather that the BIA’s alleged refusal to authorize replacement of the bridge was a taking of his property rights. The Court of Federal Claims rejected the claim. The Federal Circuit affirmed, holding that the regulatory takings claim never ripened because McGuire failed to pursue administrative remedies. Even if McGuire’s claim had ripened, he had no cognizable property interest in the bridge, which he neither possessed nor controlled because it was in a BIA right-of-way. No federal regulation gave him a property interest and he was not entitled to an easement by necessity.
View "McGuire v. United States" on Justia Law
Northrop Grumman Computing Sys., Inc. v. United States
In 2001, U.S. Immigrations and Customs Enforcement awarded Northrop a contract for lease and support of Oakley network monitoring software for one base year and three option years at about $900,000 per year. To obtain Oakley’s software, Northrop was required to pay $2,899,710, so Northrup assigned its payment rights to ESCgov for $3,296,093. ESCgov assigned its rights to Citizens, but the government was not notified. In 2005, ICE decided not to exercise the first option. Northrop sent the contracting officer a “Contract Disputes Act Claim for not Exercising Option,” citing the Contract Disputes Act, 41 U.S.C. 601. The letter did not mention the two assignments. The CO denied Northrop’s claim. The Court of Federal Claims dismissed, holding that Northrop had not supplied the CO “adequate notice” because it failed to reference potential application of the Anti-Assignment Act and Severin doctrine. While the matter was pending, Northrop filed a second claim, including documents on the financing arrangements. The CO determined that Northrop’s second claim was the same claim and declined to issue a final decision. The Claims Court again held that it lacked jurisdiction. The Federal Circuit consolidated the cases and reversed, finding that the first letter constituted a valid claim. View "Northrop Grumman Computing Sys., Inc. v. United States" on Justia Law
Cephalon, Inc. v. Watson Pharm., Inc.
The patents relate to a method of drug delivery via the mucous membrane lining or mucosa in the oral cavity. The oral mucosal route provides direct access to the bloodstream without having to travel through the gastrointestinal tract, which allows the drug to avoid the “first pass effect,” the percentage of drug lost to metabolization in the liver. Drug delivery across the oral mucosa potentially provides patients with rapid onset of action at a lower dosage. The patents disclose use of effervescent agents used as penetration enhancers, which influence drug absorption across the buccal, sublingual and gingival mucosae and use of an additional pH adjusting substance in combination with an effervescent agent for promoting the absorption. Watson filed an Abbreviated New Drug Application for a generic version of FENTORA®. In response, Cephalon instituted a patent infringement suit. The district court found that Watson’s ANDA products did not infringe and held the asserted patents invalid for lack of enablement. The Federal Circuit reversed on the issue of enablement, holding that Watson failed as a matter of law to show with clear and convincing evidence that Cephalon’s patents require undue experimentation to practice the invention. The court upheld the noninfringement finding. View "Cephalon, Inc. v. Watson Pharm., Inc. " on Justia Law
Function Media, L.L.C. v. Google, Inc.
FM sued Google for infringing three patents relating to advertising on multiple outlets such as newspapers and websites. The specification characterizes the prior art as inefficient because it requires advertisers to manually ensure that their ads conform to the differing requirements of each advertising venue. The invention is designed to eliminate this inefficiency by automatically formatting the ads to fit each publisher’s requirements and sending them out for publication. In each of the patents, a “central computer” coordinates interactions between sellers (wishing to place ads), media venues, and buyers (targets of the ads). The central computer hosts a number of databases and software processes, including the presentation rules database and the Presentation Generating Program. The district court invalidated of one of FM’s patents as indefinite and a jury found that two others were invalid and not infringed. The Federal Circuit affirmed, rejecting arguments that the court abdicated to the jury its responsibility to construe disputed claim terms; that the court incorrectly denied its motion for a new trial on the grounds that the verdict was against the weight of the evidence; and that the verdicts of infringement and invalidity are irreconcilable. View "Function Media, L.L.C. v. Google, Inc." on Justia Law
Young v. Dep’t of Housing & Urban Dev.
Young served as a Public Housing Revitalization Specialist in the Office of Public Housing in the Cleveland office of the Department of Housing and Urban Development for 10 years. Young was representing himself at an arbitration hearing, appealing his five-day suspension for disruptive behavior, misrepresentation of authority, and use of insulting language to and about other employees. One of the witnesses testifying against him was Darr, Executive Director of the Coschocton Metropolitan Housing Authority and a HUD client. Following Darr’s testimony, there was a recess; Darr claims that while he was walking down the hallway, about 25-30 feet away from Young, Young shouted from immediately outside the door of the hearing room, “[y]ou are a racist. You are a member of the KKK, and you should be shot.” Young was later placed on administrative leave; notice of proposed removal issued. Interviews were conducted after Young submitted his oral and written statements, so that Young was unaware of the content and substance of the interviews and was unable to respond to anything unearthed during those interviews. An arbitrator rejected a challenge to Young’s termination. The Federal Circuit reversed, finding that the agency violated Young’s due process rights and its own procedures.View "Young v. Dep't of Housing & Urban Dev." on Justia Law
Prasch v. Office of Pers. Mgmt.
Prasch worked as a mail carrier for the Postal Service until suffering a work-related injury, compensable under the Federal Employees’ Compensation Act. He received benefits from the Office of Workers’ Compensation Programs from December 2007 until October 2008. Prasch applied for disability retirement. OPM approved his application and deposited $14,640.27, representing retroactive retirement annuity payments from December 2007 through the approval of his application. OPM paid him another $5,869.60 in retirement annuity benefits before determining that Prasch had received FECA disability benefits from OWCP during the period that OPM was paying him retirement annuity benefits. Because governing statutes prohibit dual benefits, OPM adjusted the commencement date of Prasch’s retirement annuity and computed an overpayment of $14,703.62.and sent a proposed repayment schedule. Prasch requested a waiver of the repayment obligation, lower installments, or a compromise payment, but he did not ask for reconsideration of OPM’s decisions as to the existence of the overpayment or its amount. OPM affirmed its initial decision, finding that Prasch should have known that he could not receive dual benefits and rejecting his claim of financial hardship, but extended the time for repayment. The Merit Systems Protection denied an appeal. The Federal Circuit affirmed. View "Prasch v. Office of Pers. Mgmt." on Justia Law
Semiconductor Energy Lab. Co., Inc. v. Nagata
SEL owns the 463 patent, which names Nagata as a co-inventor. During prosecution in 1991, Nagata assigned his rights to applications and patents related to the patent to SEL’s founder Yamazaki, and subsequently signed a substitute Declaration and Assignment of those applications and patents. From 2002 to 2003, Nagata assisted SEL in a patent infringement suit against another party and was paid for his cooperation and services. In 2009, SEL sued Samsung and others for infringement and contacted Nagata for further assistance, but learned that Nagata had agreed to assist Samsung as a fact witness. Nagata gave testimony repudiating his signature on the 1991 Declarations and Assignments. Samsung then claimed that the patents, including the 463 patent, were unenforceable due to inequitable conduct. SEL sued Nagata, alleging violation of patent law, anticipatory breach of contract, slander of title, and unjust enrichment. The district court dismissed the federal claim for lack of subject matter jurisdiction under 28 U.S.C. 1338(a). The Federal Circuit affirmed; there is no federal cause of action based on assignor estoppel. View "Semiconductor Energy Lab. Co., Inc. v. Nagata" on Justia Law
Denney v. Office of Pers. Mgmt.
Denney served as a criminal investigator or special FBI agent from 1983 until her retirement in 2008. From 1983 until early 2001, Denney was eligible for and received “availability pay” under 5 U.S.C. 5545a, a form of premium pay equal to “25 percent of the rate of basic pay for the position” for criminal investigators that work at least 40 hours per week and actually work or are available to work an additional two hours per regular workday. The investigator and her supervisor must annually certify that the investigator meets the requirements. In 2001 Denney began working part-time and was no longer eligible for, and no longer received, availability pay. The Office of Personnel Management held that availability pay should not be included in “average pay” in calculating Denney’s retirement annuity. The Merit Systems Protection Board and Federal Circuit affirmed. View "Denney v. Office of Pers. Mgmt." on Justia Law
Arkema, Inc. v. Honeywell Int’l, Inc.
Before the mid-2000s, automobile manufacturers used a refrigerant called R-134a for automobile air conditioners. In 2006 the European Union enacted regulations requiring automobiles to use refrigerants with low “global warming potential.” The U.S. has not adopted similar regulations, but U.S. and foreign automobile manufacturers are both transitioning to 1234yf, which has a low global warming potential, and has become “remarkably successful,” according to Honeywell. Both Arkema and Honeywell wish to supply the industry with 1234yf, and both have invested substantial resources in its production. Arkema built a manufacturing facility in France and plans to build another facility to meet growing demand. Honeywell has a plant in New York and is developing a larger facility in Louisiana. Honeywell owns a number of patents relating to 1234yf. Arkema sought a declaratory judgment that by entering into contracts to supply 1234yf, it would not incur liability as an indirect infringer under the patents. The district court concluded that there was no justiciable controversy. The Federal Circuit reversed to allow Arkema to supplement. View "Arkema, Inc. v. Honeywell Int'l, Inc." on Justia Law